Semaglutide 10mg - Third-Party Test Results

Manufacturer: LeoLab™

Sample: Semaglutide 10mg

Date: 04 DEC 2024

LeoLab™ is proud to maintain its reputation for producing high-quality peptides, verified through rigorous third-party testing. A recent independent analysis conducted by Janoshik Analytical has confirmed the exceptional quality of LeoLab’s Semaglutide 10mg. The analysis was carried out under task number 53571, with a sample from batch G59843, tested on 04 December 2024. These tests are critical to ensuring the safety, efficacy, and reliability of our products.

The results from this latest test highlight the superior quality of LeoLab’s Semaglutide 10mg. The analysis revealed an impressive purity level of 99.776%, far exceeding standard expectations. Additionally, the test confirmed a mass measurement of 11.27 mg, demonstrating consistency and accuracy in production. These findings underscore LeoLab’s commitment to providing research-grade peptides of unparalleled quality.

Purity 99.467%

With a verified purity of 99.467%, Semaglutide 10mg sets a high standard for quality in peptide production.

Mass 11.27 mg

The accurate mass of 11.27 mg for Semaglutide 10mg reflects LeoLab™'s commitment to quality control.

Leave a Reply